Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, “Neurostyle.”
20th Congress of Gynecologists and Obstetricians
Enthusiastic Reception by Doctors and Specialists at the 20th Congress of Gynecologists and Obstetricians
The combined diabetes medicine was produced by Iranian scientists!
Researchers at Actoverco pharmaceutical company, have succeeded in producing a type of oral combination drug for diabetes that can be used to control blood sugar in individuals with type 2 diabetes.
Actoverco launches diabetes drug “Trytis”
Actoverco pharmaceutical Group produce new drug which is named “Trytis” and it will be launched as soon.
“International Labour Day”
International Labour Day is a valuable opportunity to honor and appreciate the selfless efforts and services of the honorable and hardworking workers.
Actoverco host a Futsal tournament!
Futsal tournament for active athletes in the medical and therapeutic fields with the slogan “Together for health” will be held by Actoverco pharmaceutical group in June.
Bright future for pharmaceutical industry in Iran!
Nahaleh Naraqi said that Although Iran’s economy is going through difficult years, this industry has managed to pass the year 2023 with better conditions in many indicators!
Message from Ms. Nahaleh Naraqi on the occasion of Health Week
Ms. Nahaleh naraqi stated that: “Health” is not only an individual and universal right, it is one of the fundamental rights of the members of the nation and ale all people are responsible for it.
Actoverco Holding Supported Flood Victims in Iran
Actoverco Holding and Dr. Naraghi’s charity coordinate the distribution of food packages, including various food items and medications sent to the flood-affected areas in the southeast of the country.
The presence of Actoverco at 6th job fair
Actoverco attended The 6th Iran job fair on 14th to 14th of february 2024 in Tehran